Influenza A (H3N2) Outbreak, Nepal

• Main Authors: Luke T. Daum, Michael Shaw, Alexander I. Klimov, Linda C. Canas, Elizabeth A. Macias, Debra Niemeyer, James K. Chambers, Robert Renthal, Sanjaya K. Shrestha, Ramesh P. Acharya, Shankar P. Huzdar, Nirmal Rimal, Khin S. Myint, Philip Gould
• Format: Article
• Language: English
• Published: Centers for Disease Control and Prevention 2005-08-01
• Series: Emerging Infectious Diseases
• Subjects: Keywords: Influena A; H3N2; Hemagglutinin; genetic drift; variant; Nepal
• Online Access: https://wwwnc.cdc.gov/eid/article/11/8/05-0302_article

In July 2004, an outbreak of influenza A (H3N2) was detected at 3 Bhutanese refugee camps in southeastern Nepal. Hemagglutination inhibition showed that ≈40% of the viruses from this outbreak were antigenically distinct from the A/Wyoming/3/03 vaccine strain. Four amino acid differences were observed in most of the 26 isolates compared with the A/Wyoming/3/2003 vaccine strain. All 4 substitutions are located within or adjacent to known antibody-binding sites. Several isolates showed a lysine-to-asparagine substitution at position 145 (K145N) in the hemagglutinin molecule, which may be noteworthy since position 145 is located within a glycosylation site and adjacent to an antibody-binding site. H3N2 viruses continue to drift from the vaccine strain and may remain as the dominant strains during the 2005–2006 influenza season. Thus, the 2005–2006 Northern Hemisphere vaccine strain was changed to A/California/7/2004, a virus with all 4 amino acid substitutions observed in these Nepalese isolates.